Correlation Engine 2.0
Clear Search sequence regions

  • direct (7)
  • humans (1)
  • patients (3)
  • thrombophilia (7)
  • thrombosis (2)
  • Sizes of these terms reflect their relevance to your search.

    Venous thromboembolism (VTE) is increasingly recognised in primary and secondary care practice. The arrival of direct oral anticoagulants (DOACs) has made the management of VTE easier and more convenient. Some patients established on DOACs may need screening for underlying thrombophilias as certain thrombophilic conditions are known to confer a higher thrombosis risk, although the guidelines for when and how to test for a thrombophilia, especially in a patient taking a DOAC, are unclear. This literature review aims to examine when thrombophilia screening should take place in a patient already taking a DOAC, the effect of DOACs on thrombophilia tests, and analyse whether DOACs are safe and effective in both inherited and acquired thrombophilias. © Royal College of Physicians 2021. All rights reserved.


    Jennifer Darlow, Holly Mould. Thrombophilia testing in the era of direct oral anticoagulants. Clinical medicine (London, England). 2021 Sep;21(5):e487-e491

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34493545

    View Full Text